References
- 허준. 동의보감. 서울, 남산당, p 719, 1993
- 이시진. 본초강목. 서울, 고문사, p 980, 1975
- Yamada, S. Mycelial culture method of Phellinus linteus. Korean patent, pp 92-1194, 1994
- Choi, J.H., Ha, T.M., Kim, Y.H., Rho, Y.D., Studies on the main factors affecting the mycelial growth of Phellinus linteus. Kor. J. Mycol. 24: 214-222, 1996
- Ji, J.H., Kim, M.N., Chung, C.K., Ham, S.S., Antimutagenic and cytotoxicity effects of Phellinus linteus extracts, J. Kor. Soc. Food Sci. Nutr. 29: 322-328, 2000
- Jung, M.E., Ham, S.S., Nam, S.M., Kang, I.J., Kim, S.J., Chung, C.K. Biochemical and histological effects of Phellinus linteus methanol extract on liver lipid methabolism of rat fed CCl4 and high fat, J. Kor. Soc. Food Sci. Nutr. 30(2):331-337, 2001
- Lee, H.J., Lee, H.J., Park, J.M., Song, G.Y., Kang, K.S., Kim, S.H., Study on antitumor and immunomodulatory effects of Cambodian Phellinus linteus, Kor. J. Oriental Physiology and Pathology, 16: 332-337, 2002
- Kim, J.S., Kim, J.H., Lee, H.J., Khil, J.H., Kim, S.H., Kim, D.H. A study on cytokine modulating effect of three origins of Phellinus linteus, Kor. J. Oriental Physiology and Pathology 17: 898-904, 2003
- Choi, Y.H., Huh, M.K., Ryu, C.H., Choi, B.T., Jeong, Y.K. Induction of apoptotic cell death by mycelium extracts of Phellinus linteus in human neuroblastoma cells. Int. J. Mol. Med. 14: 227-232, 2004
- Kim, G.Y., Lee, J.Y., Lee, J.O., Ryu, C.H., Choi, B.T., Jeong, Y.K., Lee, K.W., Jeong, S.C., Choi, Y.H. Partial characterization and immunostimulatory effect of a novel polysaccharide-protein complex extracted from Phellinus linteus. Biosci. Biotechnol. Biochem. 70: 1218-1226, 2006 https://doi.org/10.1271/bbb.70.1218
- Elledge, S.J., Harper, J.W. Cdk inhibitors: on the threshold of checkpoints and development. Curr. Opin. Cell Biol. 6: 847-852, 1994 https://doi.org/10.1016/0955-0674(94)90055-8
- Harper, J.W. Cyclin dependent kinase inhibitors. Cancer Surv. 29: 91-107, 1997
- Li, Y., Jenkins, C.W., Nichols, M.A., Xiong, Y. Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21. Oncogene, 9: 2261-2268, 1994
- Taylor, W.R., Stark, G.R. Regulation of the G2/M transition by p53. Oncogene 20: 1803-1815, 2001 https://doi.org/10.1038/sj.onc.1204252
-
Datto, M.B., Yu, Y., Wang, X.F. Functional analysis of thetransforming growth factor
${\beta}$ responsive elements in the WAF1/Cip1/p21 promoter. J. Biol. Chem., 270: 28623-28628, 1995 https://doi.org/10.1074/jbc.270.48.28623 - Xiong, Y., Hannon, G.J., Zhang, H., Casso, D., Kobayashi, R., Beach, D. p21 is a universal inhibitor of cyclin kinases. Nature, 366: 701-704, 1993 https://doi.org/10.1038/366701a0
- Zeng, Y.X., El-Deiry, W.S. Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene, 12: 1557-1564, 1996
- el-Deiry, W.S., Harper, J.W., O'Connor, P.M., Velculescu, V.E., Canman, C.E., Jackman, J., Pietenpol, J.A., Burrell, M., Hill, D.E., Wang, Y., Wiman, K.G., Mercer, W.E., Kastan, M.B., Kohn, K.W., Elledge, S.J., Kinzler, K.W., Vogelstain, B. WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis. Cancer Res, 54: 1169-1174, 1994
- Rosse, T., Olivier, R., Monney, L., Rager, M., Conus, S., Fellay, I., Jansen, B., Borner, C. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c. Nature, 391: 496-499, 1998 https://doi.org/10.1038/35160
- Osford, S.M., Dallman, C.L., Johnson, P.W., Ganesan, A., Packham, G. Current strategies to target the anti-apoptotic Bcl-2 protein in cancer cells. Curr. Med. Chem. 11: 1031-1039, 2004 https://doi.org/10.2174/0929867043455486
- Lowe, S.W., Ruley, H.E., Jacks, T., Housman, D.E. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell, 74: 957-967, 1993 https://doi.org/10.1016/0092-8674(93)90719-7
- Donovan, M., Cotter, T.G. Control of mitochondrial integrity by Bcl-2 family members and caspase-independent cell death. Biochim. Biophys. Acta. 1644: 133-147, 2004 https://doi.org/10.1016/j.bbamcr.2003.08.011
- Holcik, M., Gibson, H., Korneluk, R.G. XIAP: apoptotic brake and promising therapeutic target. Apoptosis, 6: 253-261, 2001 https://doi.org/10.1023/A:1011379307472
- Cheng, J.Q., Jiang, X., Fraser, M., Li, M., Dan, H.C., Sun, M., Tsang, B.K. Role of X-linked inhibitor of apoptosis protein in chemoresistance in ovarian cancer: possible involvement of the phosphoinositide-3 kinase/Akt pathway. Drug Resist. Updat. 5: 131-146, 2002 https://doi.org/10.1016/S1368-7646(02)00003-1
- Salvesen, G.S., Duckett, C.S. IAP proteins: blocking the road to death's door. Nat. Rev. Mol. Cell Biol. 3: 401-410, 2002 https://doi.org/10.1038/nrm830
- Nagata, S. Apoptosis by death factor. Cell, 88: 355-365, 1997 https://doi.org/10.1016/S0092-8674(00)81874-7
- Allen, R.T., Cluck, M.W., Agrawal, D.K. Mechanisms controlling cellular suicide: role of Bcl-2 and caspases. Cell Mol. Life Sci. 54: 427-445, 1998 https://doi.org/10.1007/s000180050171
- Rao, L., White, E. Bcl-2 and the ICE family of apoptotic regulators: making a connection. Curr. Opin. Genet. Dev. 7: 52-58, 1997 https://doi.org/10.1016/S0959-437X(97)80109-8
- Vegran, F., Boidot, R., Oudin, C., Riedinger, J.M., Lizard-Nacol, S. Implication of alternative splice transcripts of caspase-3 and survivin in chemoresistance Bull Cancer, 92: 219-226, 2005
- Giercksky, K.E. COX-2 inhibition and prevention of cancer. Best Pract. Res. Clin. Gastroenterol, 15: 821-833, 2001 https://doi.org/10.1053/bega.2001.0237
-
Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., Lee, S.S. Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-
${\kappa}B$ activation. Mutat. Res. 1: 243-268, 2001 - Poole, J.C., Andrews, L.G., Tollefsbol, T.O. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene, 269: 1-12, 2001 https://doi.org/10.1016/S0378-1119(01)00440-1
- Kyo, S., Inoue, M. Complex regulatory mechanisms of telomerase activity in normal and cancer cells: How can we apply them for cancer therapy. Oncogene, 21: 688-697, 2002 https://doi.org/10.1038/sj.onc.1205163